June 06, 2024
A Delaware federal judge has said Boston Scientific was not entitled to a new trial in a case where it was told to pay $42 million for stent systems patent infringement, but threw out a finding of willful infringement.
March 23, 2023
Boston Scientific is asking a Delaware federal court to wipe out a "poisoned" $42 million patent infringement verdict against it in a suit brought by the University of Texas, while the university is attempting to double that award.
February 21, 2023
Attorneys from Susman Godfrey and The Shore Firm recently helped secure a $42 million patent infringement win in Delaware federal court for the University of Texas and TissueGen Inc., a victory they attributed to an airtight trial strategy prevailing against Boston Scientific's significant resources.
February 01, 2023
A federal jury in Delaware has ruled that Boston Scientific infringed a patent related to stent systems, ordering the medical device giant to pay $42 million to the University of Texas and TissueGen Inc.
January 19, 2023
Pfizer is set to tell a Connecticut federal court next week that communications between its lawyers and the FBI shouldn't be disclosed in its trade secrets suit accusing former executives of stealing diabetes and cancer medication research. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.